HomeProductsBrandsAkseer Guda Qadamia Ajmali | 6...
Akseer Guda Qadamia Ajmali | 60 Gram | AJMAL
₨ 550
Akseer Guda Qadamia Ajmali decomposes the enlarged bladder gland, alleviating symptoms of Benign Prostatic Hyperplasia (BPH). Symptoms include frequent/urgent urination, nighttime urination, difficulty starting urination, weak/intermittent urine stream, post-urination dripping, and inability to empty the bladder. Although an enlarged bladder cannot be fully treated, Akseer Guda Qadamia Ajmali manages symptoms, reducing stress.
1 in stock
- Urination, also known as the frequent or urgent need to urinate, is a common symptom of BPH.
- More urination at night.
- Problems starting to urinate.
- A urine stream that is either weak or intermittent.
- Drips after urination.
- Inability to empty the bladder.
Akseer Guda Qadamia Ajmali
Akseer Guda Qadamia Ajmali decomposes the enlarged bladder gland. An enlarged prostate can cause unpleasant symptoms, such as obstructing urine flow from the bladder. It can also lead to bladder, urinary tract, and kidney issues. However, the symptoms can be managed so that they cause the affected individual less stress. Because an enlarged bladder cannot be treated at this time, it is imperative that you see a doctor immediately if you experience urination difficulties.
Symptoms
The symptoms of a swollen bladder can be annoying, but the condition itself is not life-threatening. Once an enlarged bladder has developed, it is unlikely to return to its original size. However, the symptoms can be managed so that they cause the affected individual less stress. Because an enlarged bladder cannot be treated at this time, it is imperative that you see a doctor immediately if you experience urination difficulties.
Indication:
Akseer Guda Qadamia Ajmali decomposes the enlarged gland of the bladder.
Dosage:
Five grams (one teaspoon) twice daily or as directed by a doctor.
Weight | 0.085 kg |
---|
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.